Jump Financial’s Crinetics Pharmaceuticals CRNX Stock Holding History

Jump Financial’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$581K	Buy	+16,000	New	+$715K	0.01%	1169
2025 Q3	–	Sell	-8,780	Closed	-$253K	–	1843
2025 Q2	$253K	Sell	8,780 -10,020	-53%	-$309K	﹤0.01%	1485
2025 Q1	$631K	Buy	+18,800	New	+$702K	0.01%	987
2024 Q1	–	Sell	-27,083	Closed	-$964K	–	1954
2023 Q4	$964K	Sell	27,083 -20,393	-43%	-$625K	0.03%	741
2023 Q3	$1.41M	Buy	+47,476	New	+$978K	0.05%	507
2022 Q4	–	Sell	-28,500	Closed	-$560K	–	1642
2022 Q3	$560K	Buy	+28,500	New	+$581K	0.02%	845

Other funds holding CRNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jump Financial's CRNX Position: Q1 2026 in Review

Jump Financial opened a new position in Crinetics Pharmaceuticals (CRNX) in Q1 2026: 16,000 shares worth $581K. The stake represents 0.01% of the portfolio and ranks #1169 among its holdings. This is a return to the name: Jump Financial previously reported a position in CRNX as recently as Q2 2025.

Jump Financial first reported a position in CRNX in Q3 2022 and has held it in 6 quarters since. The position peaked at $1.41M in Q3 2023. 243 funds tracked by Wall St. Rank hold CRNX as of Q1 2026.

Jump Financial held 16,000 shares of Crinetics Pharmaceuticals worth $581K as of Q1 2026.
Crinetics Pharmaceuticals was a new Jump Financial position in Q1 2026.
Crinetics Pharmaceuticals made up 0.01% of Jump Financial's portfolio in Q1 2026, its #1169 holding.
Jump Financial first reported a position in Crinetics Pharmaceuticals in Q3 2022 and has held it in 6 quarters since.
Jump Financial's Crinetics Pharmaceuticals position peaked at $1.41M in Q3 2023.
243 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.